Nomura Holdings
BCYC

Nomura Holdings’s Bicycle Therapeutics BCYC Stock Holding History

Nomura Holdings’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,095
Closed -$296K – 2180
2024
Q3 		$296K Buy
+13,095
New +$302K ﹤0.01% 1345
2024
Q1 		– Sell
-400,000
Closed -$7.23M – 1632
2023
Q4 		$7.23M Hold
400,000
– – 0.02% 544
2023
Q3 		$8.04M Hold
400,000
– – 0.02% 424
2023
Q2 		$10.2M Buy
+400,000
New +$9.29M 0.03% 341

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Nomura Holdings's BCYC Position: Q4 2024 in Review

Nomura Holdings sold out of Bicycle Therapeutics (BCYC) in Q4 2024, closing a stake of 13,095 shares — an estimated $296K sold.

Nomura Holdings first reported a position in BCYC in Q2 2023 and held it in 4 quarters. The position peaked at $10.2M in Q2 2023. 97 funds tracked by Wall St. Rank hold BCYC as of Q4 2024.

  • Nomura Holdings reported no remaining Bicycle Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Nomura Holdings sold 13,095 Bicycle Therapeutics shares in Q4 2024, an estimated $296K.
  • Nomura Holdings first reported a position in Bicycle Therapeutics in Q2 2023 and held it in 4 quarters.
  • Nomura Holdings's Bicycle Therapeutics position peaked at $10.2M in Q2 2023.
  • 97 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2024.

Based on Nomura Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.